February 1, 2024 · Form 4 insider transaction
McManus Matthew bought 13,861 shares of Bio-Techne Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.; 4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.